Development of an automated mid-scale parallel protein purification system for antibody purification and affinity chromatography

被引:9
作者
Zhang, Chi [2 ]
Long, Alexander M. [1 ]
Swalm, Brooke [1 ]
Charest, Ken [1 ]
Wang, Yan [1 ]
Hu, Jiali [1 ]
Schulz, Craig [1 ]
Goetzinger, Wolfgang [1 ]
Hall, Brian E. [1 ]
机构
[1] Amgen Inc, Therapeut Discovery, 360 Binney St, Cambridge, MA 02141 USA
[2] Univ Missouri, Dept Chem, Kansas City, MO 64110 USA
关键词
Automation; High-throughput protein purification; Affinity chromatography; Monoclonal antibody (mAb);
D O I
10.1016/j.pep.2016.08.005
中图分类号
Q5 [生物化学];
学科分类号
071010 ; 081704 ;
摘要
Protein purification is often a bottleneck during protein generation for large molecule drug discovery. Therapeutic antibody campaigns typically require the purification of hundreds of monoclonal antibodies (mAbs) during the hybridoma process and lead optimization. With the increase in high-throughput cloning, faster DNA sequencing, and the use of parallel protein expression systems, a need for high throughput purification approaches has evolved, particularly in the midsize range between 20 ml and 100 ml. To address this we modified a four channel Gilson solid phase extraction system (referred to as MG-SPE) with switching valves and sample holding loops to be able to perform standard affinity purification using commercially available columns and micro-titer format deep well blocks. By running 4 samples in parallel, the MG-SPE has the capacity to purify up to 24 samples of greater than 50 ml each using a single-step affinity purification protocol or a two-step protocol consisting of affinity chromatography followed by desalting/buffer exchange overnight (similar to 12 h run time). Our evaluation of affinity purification using mAbs and Fc-fusion proteins from mammalian cell supernatants demonstrates that the MG-SPE compared favorably with industry standard systems for both protein quality and yield. Overall the system is simple to operate and fills a void in purification processes where a simple, efficient, automated system is needed for affinity purification of midsize research samples. (C) 2016 Elsevier Inc. All rights reserved.
引用
收藏
页码:29 / 35
页数:7
相关论文
共 11 条
[1]  
Alm Tove, 2007, Biotechnology Journal, V2, P709, DOI 10.1002/biot.200700060
[2]   High-throughput antibody production [J].
Chambers, RS .
CURRENT OPINION IN CHEMICAL BIOLOGY, 2005, 9 (01) :46-50
[3]   Protein A chromatography for antibody purification [J].
Hober, Sophia ;
Nord, Karin ;
Linhult, Martin .
JOURNAL OF CHROMATOGRAPHY B-ANALYTICAL TECHNOLOGIES IN THE BIOMEDICAL AND LIFE SCIENCES, 2007, 848 (01) :40-47
[4]   Recovery and purification process development for monoclonal antibody production [J].
Liu, Hui F. ;
Ma, Junfen ;
Winter, Charles ;
Bayer, Robert .
MABS, 2010, 2 (05) :480-499
[5]   Many paths to many clones: A comparative look at high-throughput cloning methods [J].
Marsischky, G ;
LaBaer, J .
GENOME RESEARCH, 2004, 14 (10B) :2020-2028
[6]  
Nguyen Henry, 2004, Journal of Structural and Functional Genomics, V5, P23, DOI 10.1023/B:JSFG.0000029195.73810.86
[7]  
Schafer Frank, 2002, J Biomol Tech, V13, P131
[8]   An automated method for high-throughput protein purification applied to a comparison of His-tag and GST-tag affinity chromatography -: art. no. 12 [J].
Scheich, C ;
Sievert, V ;
Büssow, K .
BMC BIOTECHNOLOGY, 2003, 3 (1)
[9]   The Protein Maker: an automated system for high-throughput parallel purification [J].
Smith, Eric R. ;
Begley, Darren W. ;
Anderson, Vanessa ;
Raymond, Amy C. ;
Haffner, Taryn E. ;
Robinson, John I. ;
Edwards, Thomas E. ;
Duncan, Natalie ;
Gerdts, Cory J. ;
Mixon, Mark B. ;
Nollert, Peter ;
Staker, Bart L. ;
Stewart, Lance J. .
ACTA CRYSTALLOGRAPHICA SECTION F-STRUCTURAL BIOLOGY COMMUNICATIONS, 2011, 67 :1015-1021
[10]   High-throughput protein purification using an automated set-up for high-yield affinity chromatography [J].
Steen, J ;
Uhlén, M ;
Hober, S ;
Ottosson, J .
PROTEIN EXPRESSION AND PURIFICATION, 2006, 46 (02) :173-178